SCHEMBL6960562

SCHEMBL6960562

C#Cc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(C)(=O)=O)cn2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6166234 0.87 PTGS2 (0.55)
SCHEMBL6165811 0.87 PTGS1 (0.60)
SCHEMBL6166207 0.86 PTGS2 (0.59)
SCHEMBL6165447 0.86
SCHEMBL5322387 0.86 PTGS1 (0.58)
SCHEMBL6952041 0.84
SCHEMBL6164793 0.83
SCHEMBL6169041 0.81
SCHEMBL6163741 0.79 ABCB11 (0.65)
SCHEMBL6166707 0.79 PTGS1 (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1104758-B1 Acetylene derivatives as anti-inflammatory/analgesic agents PFIZER PROD INC (US) 2003-07-23 EP claimed
US-6506779-B1 useful in the treatment or alleviation of inflammation and other inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock. PFIZER INC. 2003-01-14 US claimed
EP-1104758-A1 Acetylene derivatives as anti-inflammatory/analgesic agents Pfizer Products Inc. (US) 2001-06-06 EP claimed
EP-1104758-B1 Acetylene derivatives as anti-inflammatory/analgesic agents PFIZER PROD INC (US) 2003-07-23 EP disclosed
EP-1104758-A1 Acetylene derivatives as anti-inflammatory/analgesic agents Pfizer Products Inc. (US) 2001-06-06 EP disclosed